Related Experiment Video
Updated: Oct 15, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review
Stefania Della Vecchia1,2, Maria Marchese3, Filippo Maria Santorelli3
1Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Calambrone, 56128 Pisa, Italy.
Emerging evidence suggests astrocytic inward rectifier potassium channel 4.1 (Kir4.1) upregulation may play a role in depression, potentially explaining treatment resistance. Further research is needed to clarify its exact contribution and therapeutic implications.
Area of Science:
- Neuroscience
- Psychiatry
- Cell Biology
Background:
- Serotonergic dysfunction is the primary hypothesis for depression, but treatment resistance suggests other mechanisms.
- Astrocytic inward rectifier potassium channel 4.1 (Kir4.1) influences neuronal excitability and glutamate metabolism.
- Kir4.1 dysfunction is an emerging area of research in mood disorders.
Purpose of the Study:
- To systematically review the existing literature on the relationship between Kir4.1 dysfunction and depression.
- To synthesize evidence from various investigation types regarding Kir4.1's role in depression pathogenesis.
Main Methods:
- Systematic literature search conducted across PubMed, Scopus, and Web of Science.
- Adherence to PRISMA statement guidelines for systematic reviews.
- Inclusion of twelve studies employing in vitro, in vivo, and post-mortem analyses.
Main Results:
- Growing evidence indicates a potential pathogenic role for Kir4.1 upregulation in depression.
- The precise contribution of Kir4.1 to different depression subtypes and comorbidities remains unclear.
- Current findings are not yet conclusive regarding Kir4.1's definitive role.
Conclusions:
- Kir4.1 upregulation is increasingly implicated in depression, offering a potential explanation for non-response to serotonergic therapies.
- Further investigation is crucial to elucidate the clinical phenotype, molecular mechanisms, and therapeutic potential associated with Kir4.1 dysfunction in depression.
- The role of Kir4.1 in depression comorbidities, such as epilepsy-depression, requires dedicated research.
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

